Kevin Corriveau

Kevin Corriveau is a the Director of U.S. Health Economics and Market Access at Johnson & Johnson MedTech, specializing in electrophysiology. His work focuses on the economic and clinical value of cardiovascular technologies, reimbursement, market access, and strategies that support efficient delivery of electrophysiology care.

Corriveau has contributed to research examining real-world outcomes in atrial fibrillation care, including same-day discharge following catheter ablation and the use of intracardiac echocardiography and three-dimensional mapping during ablation procedures. His recent work with J&J MedTech Electrophysiology has evaluated how advanced technologies and care pathways can influence clinical outcomes, healthcare utilization, and the delivery of arrhythmia care.

With extensive experience at Johnson & Johnson, Corriveau brings expertise in connecting clinical innovation with health economics, reimbursement, and market access to support the adoption of technologies that improve cardiovascular care.